Table II. Relative fold change of... | Rockefeller University Press

Table II.

Relative fold change of protein expression in OTCs with F_sIL1ra compared with F_CTRL

Cytokines/growth factors	Fold increase^a
KGF^b	5.47 ± 0.22^c
IL-6^b	6.11 ± 0.31^c
IL-8	3.47 ± 0.06^c
IL-10	3.88 ± 0.15^c
IL-16	3.78 ± 0.41^c
GMCSF^b	7.74 ± 0.31^c
CXCL1/GRO-α	2.67 ± 0.16^d
SDF-1	2.33 ± 0.07^d
I-309	4.57 ± 0.20^c
Eotaxin-2	6.19 ± 0.62^c
VEGF	0.22 ± 0.030^d
PIGF	0.25 ± 0.021^d

Cytokines/growth factors	Fold increase^a
KGF^b	5.47 ± 0.22^c
IL-6^b	6.11 ± 0.31^c
IL-8	3.47 ± 0.06^c
IL-10	3.88 ± 0.15^c
IL-16	3.78 ± 0.41^c
GMCSF^b	7.74 ± 0.31^c
CXCL1/GRO-α	2.67 ± 0.16^d
SDF-1	2.33 ± 0.07^d
I-309	4.57 ± 0.20^c
Eotaxin-2	6.19 ± 0.62^c
VEGF	0.22 ± 0.030^d
PIGF	0.25 ± 0.021^d

GRO-α, growth-related oncogene-α.

The intensities of signals were quantified by densitometry. Positive control included in the array blot was used to normalize and compare the results from different membranes. Values obtained from the control K_CTRL/F_CTRL OTC were arbitrarily assigned a value of 1. Values represent the mean fold increase as compared with control OTC (n = 3).

ChIP was performed on these genes using phospho–c-Jun antibody.

P < 0.01.

P < 0.1.

[ViewLarge]